Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STAMP: LPTAT in Children with Myopia
NCT05529056Phase 3Unknown
- Sponsor
- LitePharmTech
- Start
- May 2022
- Primary completion
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of Myopine in myopia (4 arms), sponsored by LitePharmTech. Primary endpoint: Change in Spherical Equivalent at 12 months. Status: unknown.
02
Drugs
Myopine
03
Conditions
myopia
Beyond the preview
Go deeper on NCT05529056.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05529056.